人类和病毒全基因组测序确定HPV和APOBEC是鼻状细胞癌的致癌驱动因素
medRxiv : the preprint server for health sciences
|February 23, 2026
概括
人类乳头瘤病毒 (HPV) 驱动着鼻腔状细胞癌 (SNSCC) 的进化,特别是通过较少研究的菌株. 了解这些HPV与人类的相互作用对于推进SNSCC诊断和治疗策略至关重要.
科学领域:
- 在瘤学瘤学.
- 病毒学 病毒学
- 基因组学就是基因组学.
背景情况:
- 鼻腔状细胞癌 (SNSCC) 是一种具有侵略性的头癌,治疗进展有限.
- 虽然在历史上与环境因素有关,但SNSCC显示与人类乳头瘤病毒 (HPV) 的偶然关联.
- HPV 是口腔癌的已知驱动因素,但其在SNSCC中的作用尚未完全理解.
研究的目的:
- 为了调查SNSCC中的HPV的基因组足迹.
- 为了识别参与SNSCC瘤发生的特定HPV菌株.
- 阐明SNSCC瘤进化的宿主病毒相互作用的机制.
主要方法:
- 配对宿主和SNSCC瘤的病毒全基因组测序 (WGS).
- 对病毒整合模式和宿主基因组变化的分析.
- 鉴定特定的HPV菌株及其与染色体外DNA (ecDNA) 的关联.
主要成果:
- 证实HPV是SNSCC的主要致癌驱动因素.
- 较少研究的HPV菌株 (例如,HPV45,51,39) 被确定为司机感染.
- HPV融入ecDNA和APOBEC突变发生是瘤进化的关键机制.
结论:
- 包括非正规菌株在内的HPV在SNSCC致癌过程中起着重要作用.
- 在SNSCC中,HPV-人类ecDNA安普利康是病毒瘤发生的关键调解者.
- 目前的HPV诊断面板应该扩大,包括较少研究的菌株,以全面检测SNSCC.
相关概念视频
Rous Sarcoma Virus (RSV) and Cancer
6.5K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.5K
Mechanisms of Retrovirus-induced Cancers
7.1K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
7.1K
Single Nucleotide Polymorphisms-SNPs
18.7K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
18.7K
Viral Mutations
40.0K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
40.0K
Cancers Originate from Somatic Mutations in a Single Cell
15.0K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.0K


